Low Pretreatment Serum Globulin May Predict Favorable Prognosis for Gastric Cancer Patients

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2015 Oct 19

PMID 26476541

Citations 27

Authors

Jie Chen

Ye Zhou

Yu Xu

Hui-Yan Zhu

Ying-Qiang Shi

Affiliations

Soon will be listed here.

Abstract

An elevated serum albumin (ALB) and albumin/globulin ratio (AGR) have been reported to be associated with a favorable prognosis for several types of cancer. However, little is known about prognostic significance of globulin (GLB) in gastric cancer patients. The purpose of this study was to evaluate whether GLB, ALB, and AGR analysis could predict the prognosis of patients with gastric cancer. A retrospective cohort of 186 patients with gastric cancer followed by radical surgery was recruited between January 2007 and December 2010. Levels for preoperative GLB and ALB were obtained and used to calculate the AGR. Survival analysis was used to evaluate the predictive value of GLB, ALB, and AGR. X-tile program determined 37.6, 33.4, and 1.33 as the optimal cutoff value for ALB, GLB, and AGR in terms of survival. Univariate analysis revealed that low GLB levels were significantly associated with favorable survival (P = 0.045). Conversely, low ALB levels were associated with a significantly worse survival (P = 0.000). In conclusion, low preoperative GLB level may serve as a valuable marker to predict the prognosis of gastric cancer patients.

Citing Articles

A Cohort Study on Dual Predictive Markers of Immune Combination Therapy for Advanced Non-Small Cell Lung Cancer.

Zheng M, Hu M, Liu Y, Li X, Wang G, Zhang T Biomark Insights. 2025; 20:11772719251319641.

PMID: 39957864 PMC: 11829304. DOI: 10.1177/11772719251319641.

rs762855 single nucleotide polymorphism modulates the risk for diffuse-type gastric cancer in females: a genome-wide association study in the Korean population.

Park K, Shin C, Kim N, Won S, Song C, Ohn J Gastric Cancer. 2025; 28(2):145-159.

PMID: 39862296 PMC: 11842433. DOI: 10.1007/s10120-024-01575-6.

Development and validation of a risk prediction model related to inflammatory and nutritional indexes for postoperative pulmonary infection after radical colorectal cancer surgery.

Han J, Yao T, Gao L, Gao H, Chen Y, Wang Y BMJ Open. 2025; 15(1):e087426.

PMID: 39779267 PMC: 11749061. DOI: 10.1136/bmjopen-2024-087426.

Analysis of the treatment efficacy and prognostic factors of PD-1/PD-L1 inhibitors for advanced gastric or gastroesophageal junction cancer: a multicenter, retrospective clinical study.

Yang Y, Wang Z, Xin D, Guan L, Yue B, Zhang Q Front Immunol. 2024; 15:1468342.

PMID: 39512347 PMC: 11540680. DOI: 10.3389/fimmu.2024.1468342.

The Prognostic Value of Serum Albumin to Globulin Ratio in Patients with Breast Cancer: A Retrospective Study.

Pan C, Gu Y, Ni Q Breast Cancer (Dove Med Press). 2024; 16:403-411.

PMID: 39081848 PMC: 11287198. DOI: 10.2147/BCTT.S471747.

References

Du X, Tang L, Mao Y, Sun Y, Zeng M, Kang T . The pretreatment albumin to globulin ratio has predictive value for long-term mortality in nasopharyngeal carcinoma. PLoS One. 2014; 9(4):e94473. PMC: 3981820. DOI: 10.1371/journal.pone.0094473. View

Epplein M, Xiang Y, Cai Q, Peek Jr R, Li H, Correa P . Circulating cytokines and gastric cancer risk. Cancer Causes Control. 2013; 24(12):2245-50. PMC: 3828746. DOI: 10.1007/s10552-013-0284-z. View

Thrumurthy S, Chaudry M, Hochhauser D, Mughal M . The diagnosis and management of gastric cancer. BMJ. 2013; 347:f6367. DOI: 10.1136/bmj.f6367. View

Yildirim M, Yildiz M, Duman E, Goktas S, Kaya V . Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J BUON. 2013; 18(3):728-32. View

Muller I, Munder M, Kropf P, Hansch G . Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?. Trends Immunol. 2009; 30(11):522-30. DOI: 10.1016/j.it.2009.07.007. View

Park J, Watt D, Roxburgh C, Horgan P, McMillan D . Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host. Ann Surg. 2015; 263(2):326-36. DOI: 10.1097/SLA.0000000000001122. View

Rodriguez P, Ernstoff M, Hernandez C, Atkins M, Zabaleta J, Sierra R . Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009; 69(4):1553-60. PMC: 2900845. DOI: 10.1158/0008-5472.CAN-08-1921. View

Groot Kormelink T, Powe D, Kuijpers S, Abudukelimu A, Fens M, Pieters E . Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation. Oncotarget. 2014; 5(10):3159-67. PMC: 4102799. DOI: 10.18632/oncotarget.1868. View

Camp R, Dolled-Filhart M, Rimm D . X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004; 10(21):7252-9. DOI: 10.1158/1078-0432.CCR-04-0713. View

10.

Szkandera J, Pichler M, Absenger G, Stotz M, Arminger F, Weissmueller M . The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg. 2014; 208(2):210-4. DOI: 10.1016/j.amjsurg.2013.10.030. View

11.

Azab B, Kedia S, Shah N, Vonfrolio S, Lu W, Naboush A . The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer. Int J Colorectal Dis. 2013; 28(12):1629-36. DOI: 10.1007/s00384-013-1748-z. View

12.

Wang Q, Yang Y, Zhang Y, Zou Z, Qian X, Liu B . Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer. Med Oncol. 2014; 31(12):289. DOI: 10.1007/s12032-014-0289-9. View

13.

Canna K, McArdle P, McMillan D, McNicol A, Smith G, McKee R . The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2005; 92(4):651-4. PMC: 2361875. DOI: 10.1038/sj.bjc.6602419. View

14.

Wu N, Chen G, Hu H, Pang L, Chen Z . Low pretherapeutic serum albumin as a risk factor for poor outcome in esophageal squamous cell carcinomas. Nutr Cancer. 2015; 67(3):481-5. DOI: 10.1080/01635581.2015.1004726. View

15.

Guo Y, Pan L, Du C, Ren D, Xie X . Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev. 2013; 14(1):243-8. DOI: 10.7314/apjcp.2013.14.1.243. View

16.

Gupta D, Lis C . Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010; 9:69. PMC: 3019132. DOI: 10.1186/1475-2891-9-69. View

17.

Li M, Liu X, Zhang X, Zhang J, Wang W, Zhu Y . Prognostic role of neutrophil-to-lymphocyte ratio in colorectal cancer: a systematic review and meta-analysis. Int J Cancer. 2013; 134(10):2403-13. DOI: 10.1002/ijc.28536. View

18.

Bringeland E, Wasmuth H, Fougner R, Mjones P, Gronbech J . Impact of perioperative chemotherapy on oncological outcomes after gastric cancer surgery. Br J Surg. 2014; 101(13):1712-20. DOI: 10.1002/bjs.9650. View

19.

Toiyama Y, Inoue Y, Saigusa S, Kawamura M, Kawamoto A, Okugawa Y . C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery. Anticancer Res. 2013; 33(11):5065-74. View

20.

Nakayama Y, Gotohda N, Shibasaki H, Nomura S, Kinoshita T, Hayashi R . Usefulness of the neutrophil/lymphocyte ratio measured preoperatively as a predictor of peritoneal metastasis in patients with advanced gastric cancer. Surg Today. 2014; 44(11):2146-52. DOI: 10.1007/s00595-014-0917-1. View